Sign in
4

Changes in Ownership

Elanco Animal Health Inc Filed Acc 0001415889-24-028126

Options or other derivatives

  • PRESIDENT, CEO AND DIRECTOR acquired 209.63 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Simmons Jeffrey N · PRESIDENT, CEO AND DIRECTOR

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-29 Grant or award : show line 1 in the form Deferred Stock Units +209.63 $13.21 $2,769 4,534.05 D
Loading xslF345X05/form4-12032024_101200.xml…